Agilent Technologies lifts guidance, shares extend recent NYSE gains

Agilent Technologies adjusts its outlook and benefits from a fresh analyst initiation, while the NYSE-listed shares continue a robust recovery from their May lows.

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-25, 16:58.

Agilent Technologies Inc. (US00846U1016) is in focus after a recent analyst initiation and an adjusted guidance framework. The NYSE-listed company has seen its shares recover markedly from May levels, supported by cautious but constructive commentary from Wall Street according to MarketBeat data.

What recent analyst coverage shows

Piper Sandler initiated coverage of Agilent Technologies with a Neutral rating and a price target of 150 US dollars on June 11, 2026, according to a report summarized by TheFly and Yahoo Finance. This initiation places Agilent alongside other healthcare names that analysts see as structurally relevant in diagnostics and life-science tools.

The 150 dollar target implies a moderate upside from the latest closing range and sets a reference point for investors comparing Agilent with sector peers such as Thermo Fisher Scientific and Danaher, which also operate in analytical instruments and laboratory solutions.

How the shares have traded recently

Agilent Technologies shares closed at 131.42 US dollars on the NYSE on June 24, 2026, after advancing 3.75 percent in that session, based on MarketBeat figures. Intraday, the shares traded between 128.25 and 132.72 dollars with a volume of around 2.54 million shares, indicating solid liquidity for a mid-cap healthcare-tools name.

Extended trading data show the shares changing hands at around 133.94 dollars in pre-market activity, which corresponds to an additional gain of 1.92 percent compared with the regular-session close. Short-term forecasts from PandaForecast place the stock near 131 to 132 dollars for early July, with expected volatility of around 1.2 percent.

The business behind the numbers

Agilent Technologies generates most of its revenue from analytical instruments, consumables and software used in laboratories in the pharmaceutical, chemical and academic sectors. A flagship line is its liquid chromatography and mass spectrometry systems, which help researchers separate and identify complex chemical mixtures in drug development and quality control.

The company also supplies genomics and diagnostics solutions, including instruments and reagents for cancer testing and precision medicine applications, positioning it within healthcare tools rather than pure pharmaceuticals. This diversified portfolio supports recurring revenue streams from consumables and services.

Where the shares trade today

Agilent Technologies shares (US00846U1016) trade on the NYSE. As of 2026-06-24, 15:59 Eastern time, MarketBeat reports a closing price of 131.42 US dollars.

Agilent Technologies in brief

• Company: Agilent Technologies Inc.
• ISIN: US00846U1016
• WKN: 929138
• Ticker: A
• Trading venue: NYSE
• Price (as of 2026-06-24, 15:59): 131.42 US dollars
• Market cap: around 38 billion US dollars (as of late June 2026, based on NYSE data and the latest share price).
• Sector / industry: Health Care Equipment & Supplies / Life Science Tools
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This text is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell securities.